NDC 70518-3389 – Buprenorphine and Naloxone

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC70518-3389

Product details

Brand name
Buprenorphine and Naloxone
Generic name
Buprenorphine and Naloxone
Labeler
REMEDYREPACK INC.
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA205601
Marketed since
March 16, 2022
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (1)

Package NDCDescriptionSince
70518-3389-030 TABLET in 1 BLISTER PACK (70518-3389-0)Mar 16, 2022

Other Buprenorphine and Naloxone products